In This Section
Kornelia Polyak, MD, PhD

Kornelia Polyak, MD, PhD

Dana-Farber Cancer Institute
Boston, Massachusetts

Class of 2020

For dissecting the role of intratumor heterogeneity in breast cancer and metastatic disease to develop risk assessment and personalized cancer therapy models and for extensively characterizing the metastatic potential of polyclonal tumors compared to monoclonal tumors.